Atea Pharmaceuticals Inc. (AVIR) – Mergers and Acquisitions
-
Atea Pharmaceuticals' (AVIR) Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
Atea Pharmaceuticals (AVIR) Confirms $5.75/sh + CVR Acquisition Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
-
-
-
-
-
Back to AVIR Stock Lookup